Justin Tedeschi finished his undergraduate degree at the University of Vermont where his research focused on the evolutionary history, and physiology of dystrophin and other spectrin based genes and their role in muscular dystrophy. Justin joined MGH in 2018 and the Ellinor lab in 2019 where he supports several post-doctoral associates and focuses on using gene-editing techniques in stem cell models to study genetic and molecular mechanisms of cardiac electrophysiology diseases. Justin transferred to Ultragenyx Pharmaceuticals in June 2020 as a Senior Research Associate in Cell Line Development.